Clinical implementation of genetic testing in children with neurodevelopmental disabilities in the Medicaid-enrolled population remains low.

Anne Wojcicki's nonprofit TTAM Research Institute will purchase "substantially all" of San Francisco-based 23andMe's assets.

A bankruptcy judge approved the sale of 23andMe's assets and business operations to a nonprofit led by 23andMe’s co-founder ...

The program allows patients to undergo genetic testing and high-resolution retinal imaging anonymously and provide insights ...

Anne Wojcicki’s bid to buy 23andMe, the genetic testing company she co-founded nearly 20 years ago, has received the court’s ...

A bankruptcy court this week approved the $305 million sale of genetics testing firm 23andMe to a nonprofit organization led ...

In a clinical report issued by the American Academy of Pediatrics and published online June 23 in Pediatrics, guidance is ...

By 2030, every baby born in the UK could have their entire genome sequenced under a new NHS initiative to "predict and ...

After years of collecting consumer DNA, genetic testing companies are monetizing the data. But who should profit — the ...